ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Uveitis"

  • Abstract Number: 0064 • ACR Convergence 2021

    Prevalence, Incidence and Predictor Features of Uveitis in Spondyloarthritis in a Canadian Cohort

    Vanessa Ocampo1, Mitchell Sutton2, Steve Ramkissoon1, Alexander Kaplan3, Nigil Haroon4 and Dafna Gladman5, 1University Health Network, Toronto, ON, Canada, 2University of Toronto, University Health Network, Toronto, ON, Canada, 3University of Toronto, Toronto, ON, Canada, 4Division of Rheumatology, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada, 5Schroeder Arthritis Institute, Krembil Research Institute, Toronto Western Hospital, Toronto, ON, Canada

    Background/Purpose: Spondyloarthritis (SpA) encompasses Ankylosing Spondylitis (AS), Psoriatic Arthritis (PsA), Inflammatory bowel disease- associated spondyloarthritis (IBD-SpA), Reactive Arthritis (ReA), and undifferentiated spondyloarthritis. These conditions share…
  • Abstract Number: 0198 • ACR Convergence 2021

    High Dose Intravenous Methylprednisolone Induces Rapid Improvement of Visual Acuity in Non-Infectious Uveitis of Different Immune Mediated Inflammatory Diseases

    Nuria Vegas-Revenga1, José Luis Martin-Varillas2, Vanesa Calvo-Río3, Iñigo Gonzalez-Mazon4, Lara Sánchez-Bilbao5, Emma Beltrán Catalán6, Alejandro Fonollosa7, Ana Blanco8, Ana Blanco9, Miguel Cordero Coma10, Norberto Ortego11, Ignacio Torre12, Felix Hernandez13, Santiago Muñóz-Fernández14, Maria del Mar Esteban-Ortega14, Manuel Diaz-Llopis15, Joaquin Cañal5, Juan Antonio Ventosa5, Rosalía Demetrio-Pablo16, Lucia Cristina Dominguez Casas17, Santos Castañeda18, Iván Ferraz-Amaro19, Miguel Ángel gonzalez-Gay20 and Ricardo Blanco3, 1Hospital Galdakao, Galdakao, Spain, 2Hospital Sierrallana, Torrelavega, Spain, 3Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain, 4H. U. Marques de Valdecilla, Santander, Spain, 5Hospital Universitario Marqués de Valdecilla, Santander, Spain, 6Hospital del Mar, Barcelona, Spain, 7Hospital Universitario de Cruces, Barakaldo, Spain, 8Hospital Universitario de Donostia, San Sebastián, 9Hospital Universitario de Donostia, Donostia, Spain, 10Hospital de León, Leon, Spain, 11Medicine Department, Universidad de Granada, Granada, Spain, 12Hospital Universitario de Basurto, Bilbao, Spain, 13Hospital Doctor Negrín, Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain, 14Hospital Universitario Infanta Sofia, Madrid, Spain, 15Hospital Universitario La Fe, Valencia, Spain, 16Hospital Universitario de Marqués de Valdecilla, Santander, Spain, 17Hospital Universtario San Agustin, Oviedo, Spain, 18Hospital Universitario de la Princesa, Madrid, Spain, 19Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain, 20Research group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Division of Rheumatology, Hospital Universitario Marqués de Valdecilla; School of Medicine, Universidad de Cantabria, Santander, Spain. Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

    Background/Purpose: Rapid and effective remission-inducing therapy is mandatory in uveitis to avoid irreversible structural and functional damage. In some severe cases biological agents might be…
  • Abstract Number: 0199 • ACR Convergence 2021

    Rapid Improvement in Cystoid Macular Edema with High Dose Intravenous Methylprednisolone in Non-Infectious Uveitis of Different Immune Mediated Inflammatory Diseases

    Nuria Vegas-Revenga1, José Luis Martin-Varillas2, Vanesa Calvo-Río3, Iñigo Gonzalez-Mazon4, Lara Sánchez-Bilbao5, Emma Beltrán Catalán6, Alejandro Fonollosa7, Ana Blanco8, Ana Blanco9, Miguel Cordero Coma10, Norberto Ortego11, Ignacio Torre12, Felix Hernandez13, Santiago Muñóz-Fernández14, Maria del Mar Esteban-Ortega14, Manuel Diaz-Llopis15, Joaquin Cañal5, Juan Antonio Ventosa5, Rosalía Demetrio-Pablo16, Lucia Cristina Dominguez Casas17, Santos Castañeda18, Iván Ferraz-Amaro19, Miguel Ángel gonzalez-Gay20 and Ricardo Blanco3, 1Hospital Galdakao, Galdakao, Spain, 2Hospital Sierrallana, Torrelavega, Spain, 3Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain, 4H. U. Marques de Valdecilla, Santander, Spain, 5Hospital Universitario Marqués de Valdecilla, Santander, Spain, 6Hospital del Mar, Barcelona, Spain, 7Hospital Universitario de Cruces, Barakaldo, Spain, 8Hospital Universitario de Donostia, San Sebastián, 9Hospital Universitario de Donostia, Donostia, Spain, 10Hospital de León, Leon, Spain, 11Medicine Department, Universidad de Granada, Granada, Spain, 12Hospital Universitario de Basurto, Bilbao, Spain, 13Hospital Doctor Negrín, Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain, 14Hospital Universitario Infanta Sofia, Madrid, Spain, 15Hospital Universitario La Fe, Valencia, Spain, 16Hospital Universitario de Marqués de Valdecilla, Santander, Spain, 17Hospital Universtario San Agustin, Oviedo, Spain, 18Hospital Universitario de la Princesa, Madrid, Spain, 19Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain, 20Research group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Division of Rheumatology, Hospital Universitario Marqués de Valdecilla; School of Medicine, Universidad de Cantabria, Santander, Spain. Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

    Background/Purpose: Cystoid Macular Edema (CME) is the most important cause of blindness in non-infectious uveitis (NIU) (1). Corticosteroids and conventional and/or biological immunosuppressant may be…
  • Abstract Number: 1115 • ACR Convergence 2021

    Uveitis and Inflammatory Bowel Disease: Study of 1449 Patients from a Single University Center

    Lara Sánchez-Bilbao1, María José García-García1, David Martinez-Lopez1, Iñigo Gonzalez-Mazon2, Montserrat Rivero-Tirado1, Beatriz Castro1, Javier Crespo1, Miguel Ángel gonzalez-Gay3 and Ricardo Blanco4, 1Hospital Universitario Marqués de Valdecilla, Santander, Spain, 2H. U. Marques de Valdecilla, Santander, Spain, 3Research group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Division of Rheumatology, Hospital Universitario Marqués de Valdecilla; School of Medicine, Universidad de Cantabria, Santander, Spain. Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa, 4Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain

    Background/Purpose: Inflammatory bowel disease (IBD), which includes Crohn's disease (CD), and Ulcerative colitis (UC) are related to Spondyloarthritis (SpA). Ocular manifestations (OM) are well-stablished in…
  • Abstract Number: 1307 • ACR Convergence 2021

    Uveitis in Spondyloarthritis Patients. Is There Any Specific Clinical Picture?

    MARIA LLOP VILALTELLA1, Mireia moreno1, Marta Arévalo1, Jordi Gratacós1, Maxime Dougados2 and Clementina López Medina3, 1Parc Taulí Hospital Universitari. Institut d’Investigació i Innovació Parc Taulí I3PT, Sabadell, Spain, 2Université de Paris . Department of Rheumatology - Hôpital Cochin. Assistance Publique - Hôpitaux de Paris . INSERM (U1153): Clinical epidemiology and biostatistics, PRES Sorbonne Paris-Cité. Paris, France., Paris, France, 3Department of Rheumatology, Reina Sofia Hospital, IMIBIC, University of Cordoba, Cordoba, Spain/ Department of Rheumatology, University of Paris, Cochin Hospital, Paris, France

    Background/Purpose: Uveitis is the most frequent extra-musculoskeletal manifestation in Spondyloarhtritis (SpA). Moreover, up to 50% of patients with an acute episode of uveitis develop recurrent…
  • Abstract Number: 1321 • ACR Convergence 2021

    Uveitis in Patients with Psoriatic Arthritis – a Database Analysis

    Nizar Hijaze1, Tal Gazitt2, Amir Haddad3, Muna Elias4, Idit Lavi4, Ilan Feldhamer5, Arnon Dov Cohen5, Shaul Sar4, Oren Tomkins Netzr4 and Devy Zisman4, 1Carmel medical centre, Tamra, Israel, 2Carmel Hospital, Haifa, Israel, 3Carmel Medical Centre, Haifa, Israel, 4Carmel Medical Center, Haifa, Israel, 5Clalit Health Services, Tel Aviv, Israel

    Background/Purpose: Psoriatic arthritis (PsA) belongs to the group of spondyloarthropathies in which uveitis is an associated disease . The prevalence of uveitis among PsA patients…
  • Abstract Number: 1323 • ACR Convergence 2021

    Uveitis in 406 Patients with Psoriatic Arthritis: Epidemiology, Clinical Characteristics and Relationship with Biological Treatment. Study of a Single University Center

    Ana de Vicente Delmás1, Lara Sánchez-Bilbao2, Vanesa Calvo-Río3, David Martinez-Lopez2, Alba Herrero-Morant2, Eva Galindez-Agirregoikoa4, Iñigo Gonzalez-Mazon5, Nuria Barroso García6, NATALIA PALMOU FONTANA7, Ricardo Blanco3 and Miguel Ángel gonzalez-Gay8, 1Hospital Punta de Europa, Cádiz, Spain, 2Hospital Universitario Marqués de Valdecilla, Santander, Spain, 3Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain, 4Hospital Universitario de Basurto, Bilbao, Spain, 5H. U. Marques de Valdecilla, Santander, Spain, 6Hospital Puerta del Mar, Cádiz, Spain, 7UNIVERSITARY HOSPITAL MARQUES VALDECILLA, Santander, Spain, 8Research group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Division of Rheumatology, Hospital Universitario Marqués de Valdecilla; School of Medicine, Universidad de Cantabria, Santander, Spain. Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

    Background/Purpose: Uveitis is the most common ocular manifestation of psoriatic arthritis (PsA). It has been described that uveitis in PsA tends to be insidious, chronic,…
  • Abstract Number: 1324 • ACR Convergence 2021

    Uveitis in 301 Patients with Axial Spondyloarthritis of a Single University Center: Epidemiology, Clinical Features and Biological Treatment

    Ana de Vicente Delmás1, Iñigo Gonzalez-Mazon2, Javier Rueda-Gotor3, Alba Herrero-Morant3, Nuria Barroso García4, Miguel Ángel gonzalez-Gay5 and Ricardo Blanco6, 1Hospital Punta de Europa, Cádiz, Spain, 2H. U. Marques de Valdecilla, Santander, Spain, 3Hospital Universitario Marqués de Valdecilla, Santander, Spain, 4Hospital Puerta del Mar, Cádiz, Spain, 5Research group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Division of Rheumatology, Hospital Universitario Marqués de Valdecilla; School of Medicine, Universidad de Cantabria, Santander, Spain. Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa, 6Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain

    Background/Purpose: Uveitis is the most common extra-articular manifestation of axial spondyloarthritis (axSpA). It is characterized by sudden onset, acute, anterior and unilateral. The most widely…
  • Abstract Number: 1738 • ACR Convergence 2021

    Uveitis Status in Patients with Ankylosing Spondylitis or Psoriatic Arthritis Under Secukinumab Treatment – Real World Data from a German Observational Study

    Uta Kiltz1, Jan Brandt-Jrgens2, Peter Kästner3, Elke Riechers4, Daniel Peterlik5, Annika Boas6 and Hans-Peter Tony7, 1Rheumazentrum Ruhrgebiet Herne, Ruhr-Universität Bochum, Herne, Germany, 2Rheumatologische Schwerpunktpraxis, Berlin, Germany, 3Ambulantes Rheumazentrum Erfurt, Erfurt, Germany, 4Department for Rheumatology and Immunology, Hannover Medical University, Hannover, 5Novartis Pharma GmbH, Nürnberg, Germany, 6Novartis Pharma GmbH, Nuernberg, Germany, 7Universitätsklinikum Würzburg, Wuerzburg, Germany

    Background/Purpose: Uveitis is a well-known non-musculoskeletal manifestation of spondyloarthropathies. Patients typically suffer from blurred vision, pain, and photophobia and have an increased risk of ocular…
  • Abstract Number: 144 • 2020 Pediatric Rheumatology Symposium

    Failure of Methotrexate Monotherapy and Subsequent Response to Tumor Necrosis Factor Inhibitors in Pediatric Non-Infectious Uveitis

    Ashley Cooper1, Basak Can Ermerak 2, Katie Keck 3 and Erin Stahl 1, 1Children's Mercy Kansas City, Kansas City, 2University Hospitals Cleveland Medical Center, Cleveland, 3Palmetto Health USC Medical Group, Columbia

    Background/Purpose: Pediatric non-infectious uveitis is often treated with systemic immunomodulators in a step-wise fashion, with methotrexate (MTX) followed by tumor necrosis factor alpha inhibitors (TNFi)…
  • Abstract Number: 184 • 2020 Pediatric Rheumatology Symposium

    A Survey of Uveitis Knowledge Among Juvenile Arthritis Patients and Parents

    Ashley Cooper1, Elaine Flanagan 2, Tova Ronis 3, Baruch Goldberg 4, Ashley Sherman 1, Chelsey Smith 5 and Gary Holland 6 for the CARRA investigators, 1Children's Mercy Kansas City, Kansas City, 2Emory University, Atlanta, 3Children's National Hospital, Washington, 4UT Physicians, Houston, 5Children's Mercy Kansas City, Holden, 6

    Background/Purpose: Chronic anterior uveitis is a sight-threatening complication of juvenile idiopathic arthritis (JIA).  Prompt treatment to prevent complications requires regular screening and detection of uveitis…
  • Abstract Number: 077 • 2020 Pediatric Rheumatology Symposium

    Tubulointerstitial Nephritis and Uveitis (TINU): A Pediatric Case Series with Longitudinal Followup

    Deborah Stein 1, Elizabeth Benoit 1 and Mindy Lo1, 1Boston Children's Hospital, Boston

    Background/Purpose: Tubulointerstitial nephritis and uveitis (TINU) syndrome is an uncommon condition that is likely under-recognized. The ideal treatment of both renal and ophthalmologic disease activity…
  • Abstract Number: 101 • 2020 Pediatric Rheumatology Symposium

    Uveitis Treatment in the CARRA II Registry: Tumor Necrosis Factor-inhibitors and Beyond

    Mona Riskalla1, Fatima Barbar-Smiley 2, Michael Shyne 1 and Melissa Lerman 3, 1University of Minnesota, Minneapolis, Minnesota, 2Nationwide Children's Hospital, Columbus, Ohio, 3Philadelphia, Pennsylvania

    Background/Purpose: Uveitis associated with JIA (JIA-U) is the most common extra-articular complication of JIA. As JIA-U is associated with significant risk of visual loss and…
  • Abstract Number: 121 • 2020 Pediatric Rheumatology Symposium

    Evaluating the Relationship Between Juvenile Idiopathic Arthritis Disease Activity and Uveitis Activity: A Retrospective Analysis

    Emily Liebling1, Walter Faig 2, Nicholas Moore 1, Nahomy Ledesma Vicioso 3 and Melissa Lerman 4, 1Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 2Children's Hospital of Philadelphia, Philadelphia, 3Weill Cornell Medical College, New York, New York, 4Philadelphia, Pennsylvania

    Background/Purpose: JIA – associated uveitis (JIA-U) accounts for 20-40% of childhood noninfectious uveitis and affects 10-20% of patients with JIA. Its chronic course is often…
  • Abstract Number: 187 • 2019 ACR/ARP Annual Meeting

    Epidemiology of JIA-Associated Uveitis: Environmental Factors and Disease Characteristics of a JIA-Associated Uveitis Cohort

    Theresa Hennard 1, Najima Mwase 2, Amy Cassedy 3, Joseph McDonald 4, Virginia Utz 5 and Sheila Angeles-Han6, 1Division of Rheumatology, Cincinnati Children's Hospital and Medical Center, Cincinnati, OH, 2Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 3Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, 4Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, 5Division of Ophthalmology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 6Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cinicinnati

    Background/Purpose: JIA-associated uveitis (JIA-U) is the most prevalent extra-articular manifestation of JIA and the most common type of uveitis in children. To date, environmental factors…
  • 1
  • 2
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology